The Buck Institute adds seven board members on New Year's Day

December 30, 2015/Novato, CA: The Buck Institute adds eight trustees to its board on January 1, 2016.  Six new members and two returning trustees bring a wealth of experience in construction, health care management, nursing, international planning, banking and real estate. All were appointed for three year terms.

The new board members: 

Louis Ciminelli is Chairman and CEO of LPCiminelli, a top US construction firm with offices in Buffalo and New York City and projects that involve work in China, Lithuania and Costa Rica. His civic engagement is focused on education and the arts.  He is a member of the Buck Advisory Council and lives part-time in Healdsburg, CA.

Afaf Meleis, PhD, is the former dean at the School of Nursing at the University of Pennsylvania, with a research portfolio focused on global health, immigrant and international health and women’s health.  She has held faculty positions at UCSF and UCLA and has worked in China, Sydney and Kuwait.  She will become a resident of Marin.

Cherilyn Murer, JD is President and CEO of Murer Consultants, a legal-based healthcare management consulting firm that helps clients navigate through the complex regulatory, strategic and financial issues facing healthcare providers today. A co-author of six books, Ms. Murer got her law degree from Northern Illinois University. She resides in Chicago and is a member of the Buck Advisory Council. 

Ramzi Sanbar, PhD, is Founder and Chairman of SDC Group, involved in international project development in the US, Europe, the Middle East, North Africa, and China. Residing in London, he supports international economic and cultural exchange. Dr. Sanbar received his doctorate from Paris IV University in environmental related issues and was awarded a Doctor of Law by Gonzaga University in Spokane, WA.

Wells Whitney, ScD, received his Doctorate degrees in Materials Science and Engineering from the Massachusetts Institute of Technology. He retired from Raychem in 1998 when he was diagnosed with stage IV lung cancer and became involved in helping raise money for start-ups. He is active on six nonprofit boards, three related to lung cancer. He lives in San Francisco.

Returning board members:

Bill Poland is founder of Bay West Group, an entrepreneurial commercial real estate development company which creates value in the development of urban infill, and opportunistic and adaptive reuse projects. Poland has served as President of the Olympic Club in San Francisco and was elected and served on the Town Council of Ross, CA.  He was on the Buck Board of Trustees from 2006 – 2014; he and his wife Mary are major donors to the Institute. 

Richard Rosenberg is former Chairman and CEO of the Bank of America, which grew to be the second largest bank in the US under his leadership. He is a retired commander in the US Naval Reserve and a member of the California Bar Association.  His civic involvements include board memberships on the San Francisco Symphony, the Naval War College Foundation and chairman of the University of California San Francisco Foundation.  He served on the Buck Board of Trustees from 2004 – 2012. He and his wife Barbara are major donors to the Institute.

“The Institute is entering a period of unprecedented opportunity and I am excited to work with all of the new and returning trustees as we map a course for the future,” said Brian Kennedy, PhD, Buck Institute President and CEO. “I am grateful for the board’s 

diversity of talents and experience. I thank them for making a commitment to support our mission to extend healthspan and look forward to taking advantage of their wisdom in the year ahead.” 

About the Buck Institute for Research on Aging

The Buck Institute is the U.S.’s first and foremost independent research organization devoted to Geroscience – focused on the connection between normal aging and chronic disease. Based in Novato, CA, The Buck is dedicated to extending “Healthspan”, the healthy years of human life and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and those focused on specific diseases of aging. Buck scientists strive to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer’s and Parkinson’s, cancer, cardiovascular disease, macular degeneration, diabetes, osteoporosis and stroke.  In their collaborative research, they are supported by the most recent developments in genomics, proteomics, bioinformatics and stem cell technology. For more information:

Change text size: